Nucleos(t)ide reverse transcriptase inhibitor-sparing regimens in the era of standard 3-drug combination therapies for HIV-1 infection

Nucleos(t)ide reverse transcriptase inhibitor (NRTI)-sparing regimens have often been selected as antiretroviral therapy (ART) for HIV-1 infection recently, but data for characteristics have been lacking. This study aimed to document the current status of NRTI-sparing regimens in the era of standard...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Glob Health Med
Hlavní autoři: Uchitsubo, Keita, Masuda, Junichi, Akazawa, Tsubasa, Inoue, Risako, Tsukada, Kunihisa, Gatanaga, Hiroyuki, Terakado, Hiroyuki, Oka, Shinichi
Médium: Artigo
Jazyk:Inglês
Vydáno: National Center for Global Health and Medicine 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7780279/
https://ncbi.nlm.nih.gov/pubmed/33409418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.35772/ghm.2020.01065
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky